BIOMAT Database Logo BIOMAT Database Logo

Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines. 2013

Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.

Judicial structural modifications of 5:7-fused ring-expanded nucleosides (RENs), based on molecular modeling studies with one of its known targets, human RNA helicase (hDDX3), led to the lead, novel, 5:7-5-fused tricyclic heterocycle (1). The latter exhibited promising broad-spectrum in vitro anti-cancer activity against a number of cancer cell lines screened. This paper describes our systematic, albeit limited, structure-activity relationship (SAR) studies on this lead compound, which produced a number of analogs with broad-spectrum in vitro anti-cancer activities against lung, breast, prostate, and ovarian cancer cell lines, in particular compounds 15i, 15j, 15m and 15n which showed IC(50) values in submicromolar to micromolar range, and are worthy of further explorations. The SAR data also enabled us to propose a tentative SAR model for future SAR efforts for ultimate realization of optimally active and minimally toxic anti-cancer compounds based on the diimidazo[4,5-d:4',5'-f][1,3]diazepine structural skeleton of the lead compound 1.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Synthesis and structure-activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agents.
May 2018, Molecular diversity,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.
February 2010, Bioorganic & medicinal chemistry letters,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
7-Methyl-5-[(4-methyl-benzene)-sulfon-yl]-2H,5H-[1,3]dioxolo[4,5-f]indole: crystal structure and Hirshfeld analysis.
February 2018, Acta crystallographica. Section E, Crystallographic communications,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Design, synthesis and evaluation of the anti-breast cancer activity of 1,3-oxazolo[4,5-d]pyrimidine and 1,3-oxazolo[5,4-d]pyrimidine derivatives.
April 2023, RSC medicinal chemistry,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
June 2016, Bioorganic & medicinal chemistry,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
An efficient, short synthesis and potent anti-hepatitis B viral activity of a novel ring-expanded purine nucleoside analogue containing a 5:7-fused, planar, aromatic, imidazo[4,5-e][1,3]diazepine ring system.
March 1999, Nucleosides & nucleotides,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
November 2002, Journal of medicinal chemistry,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
4-(2,7-Dimethyl-4-oxo-1,3-thia-zolo[4,5-d]pyridazin-5-yl)benzene-sulfonamide.
July 2011, Acta crystallographica. Section E, Structure reports online,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
IMIDAZO(4,5-D)PYRIDAZINES. II: THE SYNTHESIS OF 4(7)-METHOXY-7(4)-METHYLIMIDAZO(4,5-D)PYRIDAZINES (1)
October 1963, Arzneimittel-Forschung,
Atul Kondaskar, and Shilpi Kondaskar, and James C Fishbein, and Brandon A Carter-Cooper, and Rena G Lapidus, and Mariola Sadowska, and Martin J Edelman, and Ramachandra S Hosmane
Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
September 2020, Bioorganic chemistry,
Copied contents to your clipboard!